DCAF8L1 as A Potential Drug Target and Biomarker for Various Diseases

Target Name: DCAF8L1

NCBI ID: G139425

DCAF8L1

DCAF8L1 as A Potential Drug Target and Biomarker for Various Diseases

DCAF8L1 (DC8L1_HUMAN) is a protein that is expressed in various tissues of the human body. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells. Specifically, DCAF8L1 is a member of the DCAF8 family, which is known for its role in regulating mitochondrial dynamics. In this article, we will discuss DCAF8L1 as a drug target and its potential as a biomarker for various diseases.

DCAF8L1 as a Drug Target

DCAF8L1 has been identified as a potential drug target due to its involvement in various cellular processes that are important for human health. One of the key functions of DCAF8L1 is its role in the regulation of mitochondrial dynamics. Mitochondria are organelles that are responsible for generating energy for the cell through a process called cellular respiration. DCAF8L1 is involved in the regulation of the dynamics of mitochondria, which is critical for the proper functioning of the cell.

Studies have shown that DCAF8L1 plays a key role in the regulation of mitochondrial fusion, which is the process by which new mitochondria are formed from existing ones. DCAF8L1 has been shown to interact with the proteinBeclin-1 (BECN1), which is also involved in the regulation of mitochondrial fusion. This interaction between DCAF8L1 and Beclin-1 suggests that DCAF8L1 may be a useful target for drugs that are designed to modulate mitochondrial dynamics.

In addition to its role in the regulation of mitochondrial dynamics, DCAF8L1 has also been shown to be involved in the regulation of cellular signaling pathways that are important for human health. For example, DCAF8L1 has been shown to interact with the proteinFAK (focal adhesion kinase), which is involved in cell-cell adhesion and the regulation of various signaling pathways. This interaction between DCAF8L1 and FAK suggests that DCAF8L1 may be a useful target for drugs that are designed to modulate cellular signaling pathways.

DCAF8L1 as a Biomarker

DCAF8L1 has also been identified as a potential biomarker for various diseases. For example, studies have shown that DCAF8L1 is expressed in the breast tissue, and high levels of DCAF8L1 have been associated with the development of breast cancer. Additionally, DCAF8L1 has been shown to be involved in the regulation of cellular processes that are important for the development and progression of various diseases. For example, DCAF8L1 has been shown to play a key role in the regulation of angiogenesis, which is the process by which new blood vessels are formed.

In addition to its role in the regulation of angiogenesis, DCAF8L1 has also been shown to be involved in the regulation of cellular signaling pathways that are important for the development and progression of diseases. For example, DCAF8L1 has been shown to interact with the proteinPD-L1 (PD-L1), which is involved in the regulation of immune responses and the development of cancer. This interaction between DCAF8L1 and PD-L1 suggests that DCAF8L1 may be a useful biomarker for diseases that are characterized by the over-regulation of immune responses or the development of cancer.

Conclusion

In conclusion, DCAF8L1 (DC8L1_HUMAN) is a protein that is expressed in various tissues of the human body and is involved in the regulation of various cellular processes that are important for human health. The regulation of mitochondrial dynamics and the regulation of cellular signaling pathways are key functions of DCAF8L1. Additionally, DCAF8L1 has

Protein Name: DDB1 And CUL4 Associated Factor 8 Like 1

The "DCAF8L1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DCAF8L1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets